DrugDashboards

Olopatadine Hcl

Olopatadine Hcl · OLOPATADINE HYDROCHLORIDE 1 mg/mL · Solution/ Drops · Ophthalmic · Sola Pharmaceuticals

NDC 70512-0520-05 · 1 BOTTLE, PLASTIC in 1 CARTON / 5 mL in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $1.27 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.27per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$5.77per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$4.20per MLweighted avg manufacturer price $2.4025 · Jul 1, 2025332% of what pharmacies pay — higher than 95% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Jul 2022Sep 2026$1.27
51 price points · per ML · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Medicaid spend (2025)

$463,091
30,910 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for olopatadine hcl (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA203152
TE code
Approval date
Dec 7, 2015
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Olopatadine Hcl (Solution/ Drops)

LabelerStrengthFirst seenLast seen
Cardinal Health 110, Llc. Dba LeaderOLOPATADINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Sola PharmaceuticalsOLOPATADINE HYDROCHLORIDE 1 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olopatadine Hcl — NDC 70512-0520-05," retrieved September 3, 2026, https://drugdashboards.com/drug/70512052005.

Free to cite with attribution — see how the data is put together.